APCER Pharma Announces That LPC Pharma Group To Outsource Pharmacovigilance/Drug Safety To APCER

Main Category: Pharmacy / Pharmacist
Also Included In: Pharma Industry / Biotech Industry
Article Date: 09 Feb 2010 - 0:00 PDT

email icon email to a friend   printer icon printer friendly   write icon opinions  

Current Article Ratings:

Patient / Public:1 star

1 (1 votes)

Healthcare Prof:not yet rated


APCER Pharma announced that LPC Pharma Group is outsourcing its http://www.pharmacovigilance/drug safety operations to APCER.

APCER is a leading global provider of comprehensive drug safety, regulatory services and risk management programs for pharmaceutical, biotechnology, medical device and consumer products companies.

LPC, based in Luton, specialises in the supply of branded and generic medicines across the UK. It owns the intellectual property for over 150 licences enabling supply of own label and several brands such as Uvistat sun cream, Dalivit Multivitamin Drops and Hill's Balsam for Chesty and Dry Cough.

LPC Director Satnam Butter said, "APCER uses best in class, validated processes and technology. Their staff have excellent training and qualifications. Outsourcing our pharmacovigilance operations to the experts at APCER allows LPC to focus our resources on our areas of expertise."

Michael Reynolds, APCER's Head of Sales and Marketing for Europe, Asia and Africa, said, "We're delighted to be working with LPC. Maintaining the system is one of the most expensive, time-consuming burdens facing a pharmaceutical company. APCER is 100% committed to our customers' successes. We maintain continuous contact through visits and regular updates, which enables smooth and efficient implementations. Our team becomes an extension of every client's operation."

Pharmaceutical companies must invest more resources and budget to manage their compliance with pharmacovigilance regulatory requirements within ICH regions. APCER's pharmacovigilance/drug safety experts provide a complete range of services based on a fully electronic platform which is compliant with ICH-E2B (EU) and 21 CFR part 11 (US-FDA) regulatory requirements.

Source
APCER Pharma

Article adapted by Medical News Today from original press release.
Visit our pharmacy / pharmacist section for the latest news on this subject.
There are no references listed for this article.
Please use one of the following formats to cite this article in your essay, paper or report:

MLA
APCER Pharma. "APCER Pharma Announces That LPC Pharma Group To Outsource Pharmacovigilance/Drug Safety To APCER." Medical News Today. MediLexicon, Intl., 9 Feb. 2010. Web.
16 Feb. 2012. <http://www.medicalnewstoday.com/releases/178503.php>

APA
APCER Pharma. (2010, February 9). "APCER Pharma Announces That LPC Pharma Group To Outsource Pharmacovigilance/Drug Safety To APCER." Medical News Today. Retrieved from
http://www.medicalnewstoday.com/releases/178503.php.

Please note: If no author information is provided, the source is cited instead.


Pharmacy / Pharmacist

Most Popular Articles



Follow Our Pharmacy News On Twitter

Follow Us On Twitter
Get the latest news for this category delivered straight to your Twitter account. Simply visit our Pharmacy / Pharmacist Twitter account and select the 'follow' option.



View list of all 'What Is...' articles »